You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radium Ra 223 dichloride

Showing 26 - 50 of 1,687
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)

Completed
Has Results
  • Breast Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Yuma, Arizona
  • +93 more
Nov 4, 2022

Gather More Information About Bone Fractures and Survival in

Completed
  • Metastatic Castration-Resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Other standard care
  • Database Study, Sweden
    Database Study
Jul 1, 2021

Radium-223 Used for Treatment of Metastatic Castration Resistant

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Homewood, Alabama
  • +71 more
Mar 25, 2022

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Anchorage, Alaska
  • +163 more
Jan 18, 2023

Metastatic Castrate Resistant Prostate Cancer (mCRPC) Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), NAH

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer (mCRPC)
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • NAH therapy
  • Castle Hill, New South Wales, Australia
  • +156 more
Jan 13, 2023

Sarcoma Trial in Houston (Ra-223 Dichloride)

Completed
Has Results
  • Sarcoma
  • Ra-223 Dichloride
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 13, 2021

Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

Prostate Cancer Trial in New York (Abiraterone acetate, Prednisone, Radium-223 dichloride)

Completed
  • Prostate Cancer
  • Abiraterone acetate
  • +5 more
  • New York, New York
  • +1 more
Dec 10, 2021

Metastatic Prostate Cancer, Pain Trial in New York, Chapel Hill (Radium-223)

Completed
  • Metastatic Prostate Cancer
  • Pain
  • New York, New York
  • +2 more
Feb 3, 2022

Castration-resistant Prostate Cancer, Bone Metastases Trial in Osaka (Ra-223 in combination with enzalutamide)

Active, not recruiting
  • Castration-resistant Prostate Cancer
  • Bone Metastases
  • Ra-223 in combination with enzalutamide
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
Sep 8, 2021

Prostate Cancer Metastatic to Bone Trial in Amsterdam (Radium-223 chloride, Rhenium-188-HEDP)

Active, not recruiting
  • Prostate Cancer Metastatic to Bone
  • Amsterdam, Netherlands
    VU University Medical Center
Nov 16, 2020

Tumor Metastasis / Bone and Bones Trial in Worldwide (Data Collection)

Recruiting
  • Neoplasm Metastasis / Bone and Bones
  • Data Collection
  • Anchorage, Alaska
  • +156 more
Aug 22, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Prostate Carcinoma Metastatic to the Bone Trial in United States (Enzalutamide, Radium ra 223 dichloride)

Completed
  • Prostate Carcinoma Metastatic to the Bone
  • Towson, Maryland
  • +3 more
Mar 15, 2019

Prostate Gland Cancer, Which Spreads to Other Parts of Body, Who

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Radium-223 (Xofigo, BAY88-8223)
  • +2 more
  • Whippany, New Jersey
    US Flatiron prostate cancer database
Dec 8, 2021

Bone Marrow Suppression and Recovery During Radionuclide

Completed
  • Castration-resistant Prostate Cancer
  • Blood sampling
  • Copenhagen, Denmark
    Rigshospitalet
Nov 4, 2022

Multiple Myeloma Trial in Korea, Republic of, Spain, United States (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo,

Terminated
Has Results
  • Multiple Myeloma
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Encinitas, California
  • +6 more
Feb 25, 2020

Metastatic Renal Cell Carcinoma Trial in Boston (Pazopanib, Sorafenib, Radium-223)

Completed
  • Metastatic Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Mar 3, 2020

Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Background hormonal therapy)

Terminated
Has Results
  • Breast Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +2 more
  • Bakersfield, California
  • +70 more
Jul 29, 2020

Patterns in mCRPC

Completed
  • Prostatic Neoplasms, Castration-Resistant
  • Xofigo (Radium-223 dichloride, BAY88-8223)
  • Whippany, New Jersey
    Whippany
Mar 30, 2020

Metastatic Castration-Resistant Prostatic Cancer Trial in Belgium, Sweden (Enzalutamide Oral Capsule [Xtandi], Abiraterone Oral

Recruiting
  • Metastatic Castration-Resistant Prostatic Cancer
  • Enzalutamide Oral Capsule [Xtandi]
  • +6 more
  • Aalst, Belgium
  • +22 more
Sep 28, 2021

Post-eRADicAte - A Long Term Follow up of Subjects That

Unknown status
  • Prostate Cancer Metastatic
    • Towson, Maryland
    • +4 more
    Mar 15, 2019

    Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • (no location specified)
    Mar 6, 2023

    mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone

    Withdrawn
    • Prostatic Neoplasms, Castration-Resistant
    • radium Ra 223 dichloride (Xofigo, BAY88-8223)
    • +2 more
    • (no location specified)
    Oct 29, 2018

    Castrate-Resistant Prostate Cancer Trial in United States (Atezolizumab, Radium-223 Dichloride)

    Completed
    • Castrate-Resistant Prostate Cancer
    • Duarte, California
    • +16 more
    Sep 23, 2019